Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council
November 06 2009 - 1:00PM
Business Wire
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, today
announced the Mass Technology Leadership Council, Inc. named Phase
Forward Private Sector Company of the Year at the 2009 Mass
Technology Leadership Awards in Boston last night. Honoring
Massachusetts companies and individuals who best exemplify
leadership and excellence in business and technology, the
Technology Leadership Awards recognize outstanding achievement in
both the development and deployment of technologies.
“Phase Forward has established itself as one of Massachusetts’
premier technology success stories,” said Tom Hopcroft, president
and CEO of the Mass Technology Leadership Council. “Under the
direction of an excellent executive team the company’s consistent
drive to innovate has enabled it to flourish. We congratulate Phase
Forward on distinguishing itself in a region whose commitment to
innovation consistently produces very successful technology
companies.”
Accepting the award was Phase Forward Chairman and CEO Bob
Weiler, himself a recipient of the CEO of the year award at the
2006 Mass Technology Leadership Awards. “I proudly accept this
award on behalf of the Phase Forward employees and customers around
the world who have made our company the success it is today,” said
Weiler. “On this occasion I would also like to acknowledge Phase
Forward’s founder Paul Bleicher, whose vision for automating
clinical trials and entrepreneurial drive set our company in
motion. We are ardent supporters of the great work MTLC does
advancing technological innovation in Massachusetts, and proud to
be honored by an organization of this caliber.”
About Mass Technology Leadership Council, Inc.
Formed by the powerful combination of Mass Software Council and
New England Business and Technology Association, Inc., the
organization is dedicated to fostering entrepreneurship and
promoting the success of companies that develop and deploy
technology across industry sectors. The Mass Technology Leadership
Council accomplishes its mission by conducting educational programs
and hosting signature events, facilitating networking between
industry executives and potential partners, investors, and
customers, sponsoring research on the industry, engaging in
activities to enhance the quality and quantity of the next
generation of technology professionals, advocating in favor of
technology policies that promote innovation and entrepreneurship,
and recognizing industry-leading companies and people.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Cautionary Statement
Certain statements made in this press release that are not based
on historical information are forward-looking statements which are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. This press release
contains express or implied forward-looking statements relating to,
among other things, the performance of Phase Forward’s products and
services, continued market acceptance of Phase Forward’s products
and services, and the ability of Phase Forward’s customers to
realize benefits from the use of Phase Forward’s products and
services. These statements are neither promises nor guarantees, but
are subject to a variety of risks and uncertainties, many of which
are beyond Phase Forward's control, which could cause actual
results to differ materially from those contemplated in these
forward-looking statements. In particular, the risks and
uncertainties include, among other things, the ability of Phase
Forward’s customers to realize benefits from the use of its
products and services, the possibility that customers’ needs or
plans may change over time, and the introduction or improvement of
products and services competitive with those of Phase Forward.
Existing and prospective investors are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date hereof. Phase Forward undertakes no obligation to
update or revise the information contained in this press release,
whether as a result of new information, future events or
circumstances or otherwise. For additional disclosure regarding
these and other risks faced by Phase Forward, see the disclosure
contained in Phase Forward's public filings with the Securities and
Exchange Commission including, without limitation, its most recent
Annual Report on Form 10-K.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2024 to Aug 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Aug 2023 to Aug 2024